Sartorius Stedim Biotech (DIM) News Today €192.00 +8.70 (+4.75%) (As of 11/1/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartHeadlines All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period France shares higher at close of trade; CAC 40 up 0.80%November 2 at 7:56 AM | msn.comSartorius Stedim Biotech (EPA:DIM) Shares Down 2.5% - Here's What HappenedOctober 31 at 2:29 AM | americanbankingnews.comJefferies Sticks to Their Hold Rating for Sartorius (0NIR)October 28, 2024 | markets.businessinsider.comKepler Capital Remains a Sell on Sartorius (0NIR)October 19, 2024 | markets.businessinsider.comSartorius AG (SARTF) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic GrowthOctober 18, 2024 | finance.yahoo.comRBC Capital Keeps Their Buy Rating on Sartorius Stedim Biotech (0RG8)October 18, 2024 | markets.businessinsider.comSartorius Stedim Biotech SA (SDMHF) Q3 2024 Earnings Call Highlights: Navigating Market ...October 18, 2024 | finance.yahoo.comFrance shares higher at close of trade; CAC 40 up 1.22%October 17, 2024 | msn.comFrance stocks higher at close of trade; CAC 40 up 1.22%October 17, 2024 | msn.comMatica Bio and CytoImmune Establish a Strategic Partnership for Cell Therapy Development and ManufacturingOctober 10, 2024 | businesswire.comSenior Life Sciences Executives Launch Enovo Life Sciences, in Partnership with Warburg PincusOctober 7, 2024 | tmcnet.comJ.P. Morgan Reaffirms Their Buy Rating on Sartorius (0NIR)September 27, 2024 | markets.businessinsider.comSDMHF Sartorius Stedim Biotech S.A.September 21, 2024 | seekingalpha.comSartorius Stedim Biotech S.A. (56S1.DE)September 16, 2024 | sg.finance.yahoo.comFrance shares mixed at close of trade; CAC 40 up 0.99%September 9, 2024 | msn.comFrance shares lower at close of trade; CAC 40 down 1.07%September 7, 2024 | msn.comKepler Capital Sticks to Its Sell Rating for Sartorius (0NIR)September 6, 2024 | markets.businessinsider.comKepler Capital Sticks to Their Hold Rating for Sartorius Stedim Biotech (0RG8)September 6, 2024 | markets.businessinsider.comRBC Capital downgrades Sartorius (0NIR) to a HoldSeptember 2, 2024 | markets.businessinsider.comFrance shares mixed at close of trade; CAC 40 down 0.32%August 27, 2024 | msn.comSartorius Stedim Biotech S.A. (DIMP.XC)August 16, 2024 | finance.yahoo.comBlackRock Greater Europe Investment Trust: High-Quality Fund in Underappreciated RegionAugust 14, 2024 | uk.investing.comViroCell Biologics Completes Oversubscribed FinancingAugust 14, 2024 | finance.yahoo.comSartorius Stedim Biotech S.A. (SRTOY)August 13, 2024 | finance.yahoo.comSRTOY Sartorius Stedim Biotech S.A.August 1, 2024 | seekingalpha.comSartorius (0NIR) Receives a Buy from J.P. MorganJuly 29, 2024 | markets.businessinsider.comSartorius Stedim Biotech S.A. (DIM.VI)July 26, 2024 | uk.finance.yahoo.comSartorius Stedim Biotech S.A. (SDMHF) H1 2024 Earnings Call TranscriptJuly 20, 2024 | seekingalpha.comSartorius Stedim Biotech SA: Half-year results 2024 of SartoriusStedimBiotech -2-July 19, 2024 | finanznachrichten.deSartorius Stedim Biotech S.A. GAAP EPS of €1.08, revenue of €1.37BJuly 19, 2024 | msn.comHere's what to expect from Sartorius Stedim Biotech's earnings reportJuly 19, 2024 | markets.businessinsider.comSartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024July 19, 2024 | markets.businessinsider.comRGA Investment Advisors Q1 2024 Investment CommentaryMay 24, 2024 | seekingalpha.comLondon Still Europe’s Share Sale Capital Even With Few IPOsMay 20, 2024 | uk.finance.yahoo.comFrance stocks lower at close of trade; CAC 40 down 0.26%May 17, 2024 | msn.comFrance stocks lower at close of trade; CAC 40 down 0.63%May 16, 2024 | msn.comSingle-use Bioreactors Market to hit USD 9.2 Bn by 2032, says Global Market Insights Inc.April 30, 2024 | finance.yahoo.comGlobal Microcarriers Market: Insights into the market's present scenario and future projections (2024-2033)April 20, 2024 | uk.finance.yahoo.comSartorius Aktiengesellschaft (SARTF) Q1 2024 Earnings Call TranscriptApril 20, 2024 | seekingalpha.comSartorius Stedim Biotech S.A.April 19, 2024 | wsj.comSartorius Stedim Biotech publishes unaudited -2-April 18, 2024 | finanznachrichten.deSartorius Stedim Biotech publishes unaudited first quarter results for 2024April 18, 2024 | markets.businessinsider.comSartorius Stedim Biotech S.A. goes ex dividend tomorrowApril 1, 2024 | msn.comResolutions of the Annual Shareholders’ Meeting of Sartorius Stedim Biotech S.A.March 26, 2024 | markets.businessinsider.comFrance stocks lower at close of trade; CAC 40 down 0.00%March 25, 2024 | msn.comBoard of Directors of Sartorius Stedim Biotech resolves to propose a dividend of 0.69 euros per share to the Annual Shareholders’ MeetingFebruary 7, 2024 | markets.businessinsider.comEQS-Adhoc: SARTORIUS AG: Sartorius launches placement of up to 200 million euros of treasury preference shares through accelerated bookbuildingFebruary 6, 2024 | markets.businessinsider.comSartorius Stedim Biotech S.A. announces an -2-February 6, 2024 | finanznachrichten.deSartorius Stedim Biotech SAJanuary 30, 2024 | morningstar.comSartorius aims to grow again in 2024 after business slumpJanuary 26, 2024 | reuters.com Get Sartorius Stedim Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for DIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto Crash Ahead? (27 Experts Weigh In) (Ad)Your Portfolio Could Be at RISK Emergency summit reveals crypto could save you! Click here to reserve your spot at the emergency crypto summit now. DIM Media Mentions By Week DIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DIM News Sentiment▼0.340.41▲Average Medical News Sentiment DIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DIM Articles This Week▼31▲DIM Articles Average Week Get Sartorius Stedim Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for DIM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fielmann Group News Carl Zeiss Meditec News Gerresheimer News Fresenius SE & Co. KGaA News Genfit News Sanofi News Siemens Healthineers News Bayer Aktiengesellschaft News Merck KGaA News Fresenius Medical Care News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (EPA:DIM) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredMusk Says ‘Dollar Will Be Worth Nothing…’Elon Musk just issued an urgent warning… It's no secret that Musk is able to move markets with his words…Crypto 101 Media | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredNvidia warning urgentI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sartorius Stedim Biotech S.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sartorius Stedim Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
